The cysteine-cysteine family of chemokines RANTES, MIP-1α, and MIP-1β induce trypanocidal activity in human macrophages via nitric oxide

Infection and Immunity

Volumn 66, Issue 10, 1998, Pages 4690-4695

  Villalta, Fernando ^a   Zhang, Yuan ^a   Bibb, Kartz E ^a   Kappes, John C ^b   Lima, Maria F ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES;

ANTIPROTOZOAL ACTIVITY; ARTICLE; FLAGELLATE; HOST PARASITE INTERACTION; HOST RESISTANCE; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

EID: 0031658342     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.10.4690-4695.1998     Document Type: Article

References (54)

1. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-la, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958.
2. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675-705.
3. Baggiolini, M. B., B. Dewald, and B. Moser. 1994. lnterleukin-8 and related C chemotactic cytokines-CXC and CC-chemokines. Adv. Immunol. 55:97-179.
4. Brener, Z. 1973. Biology of Trypanosoma cruzi. Annu. Rev. Microbiol. 27:347-382.
5. Bukrinsky, M. I., H. S. L. Nottet, H. Scmidtmayerova, L. Dubrovsky, C. R. Flanagan, M. E. Mullins, S. A. Lipton, and H. E. Gendelman. 1995. Regulation of nitric oxide synthasc activity in human immunodeficiency virus type (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J. Exp. Med. 181:735-745.
6. + T cells. Science 270:1811-1815.
7. Cohen, M. C., and S. Cohen. 1996. Cytokine function. A study in biologic diversity. Am. J. Clin. Pathol. 105:589-598.
8. Cook, D. N. 1996. The role of MIP-1α in inflammation and hematopoiesis. J. Leukoc. Biol. 59:61-66.
9. Del Castillo, M. 1990. AIDS and Chagas' disease with central nervous system tumor-like lesion. Am. J. Med. 88:693-694.
10. Denis, M. 1991. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leukoc. Biol. 49:380-387.
11. Dixit, V. M., S. Greem, V. Sarma, L. Holzman, F. W. Wolf, K. O'Rourke, P. A. Ward, E. V. Prochwnik, and R. M. Marks. 1990. Tumor necrosis factor alpha: induction of novel gene products in human endothelial cells including a macrophage-specific chemokine. J. Biol. Chem. 265:2973-2978.
12. Dumarey, C. H., V. Labrousse, N. Rastogi, B. B. Vargatig, and M. Bachelet. 1994. Selective Mycobacterium avium-induced production of nitric oxide by human monocyte-derived macrophages. J. Leukoc. Biol. 56:36-40.
13. Gao, J. L., and P. M. Murphy. 1994. Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J. Biol. Chem. 269:28539-28542.
14. Gazzinelli, R. T., I. P. Oswald, S. Hieny, S. L. James, and A. Sher. 1992. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanisms inhibitable by interleukin-10 and transforming growth factor beta. Eur. J. Immunol. 22:2501-2506.
15. Green, S. J., C. A. Nacy, and M. S. Meltzer. 1991. Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J. Leukoc. Biol. 50:93-103.
16. Hedrick, J. A., and A. Zlotnik. 1997. Identification and characterization of a novel β-chemokine containing six conserved cysteins. J. Immunol. 159:1589-1593.
17. Holscher, C., G. Kohler, U. Muller, H. Mossman, G. U. Schaub, and F. Brombacher. 1998. Defective nitric oxide effect or functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun. 66:1208-1215.
18. James, S. L. 1995. Role of nitric oxide in parasitic infections. Microbiol. Rev. 50:533-547.
19. King, J. M., K. D. Srivastava, G. B. Stefano, T. V. Bilfinger, W. F. Bahou, and H. L. Magazine. 1997. Human monocyte adhesion is modulated by endothelin B receptor-coupled nitric oxide release. J. Immunol. 158:880-886.
20. Kolb, J. P., N. Paul-Eugene, C. Damias, K. Yamaoka, and J. C. Drapier. 1994. Interleukin-4 stimulates cGMP production by INFN-γ-activated human macrophages. Involvement of the nitric oxide synthase pathway. J. Biol. Chem. 269:9811-9816.
21. + cells. Immunol. Today 17:217-224.
22. Lima, M. F., and F. Villalta. 1988. Host-cell attachment by Trypanosoma cruzi: identification of an adhesion molecule. Biochem. Biophys. Res. Commun. 188:256-262.
23. Lima, M. F., and F. Villalta. 1989. Trypanosoma cruzi trypomastigote clones differentially express a cell adhesion molecule. Mol. Biochem. Parasitol. 33:159-170.
24. Lima, M. F., Y. Zhang, and F. Villalta. 1997. β-chemokines that inhibit HIV-1 infection of human macrophages stimulate uptake and promote destruction of Trypanosoma cruzi by human macrophages. Cell. Mol. Biol. 43:1067-1076.
25. Maragos, C. M., D. Morley, D. A. Wink, T. M. Dunams, J. E. Saavedra, A. Huffman, A. A. Bove, L. Isaac, J. A. Hrabie, and L. K. Keefer. 1991. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J. Med. Chem. 34:3242-3247.
26. Martin, J. H., and S. W. Edwards. 1993. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas nitrogen intermediates are employed by macrophages in tumor killing. J. Immunol. 150:3478-3486.
27. Munoz-Fernandez, M. A., M. A. Fernandez, and M. Fresno. 1992. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Hur. J. Immunol. 22:301-307.
28. Munoz-Fernandez, M. A., M. A. Fernandez, and M. Fresno. 1992. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-α and IFN-γ through a nitric oxide-dependent mechanism. Immunol. Lett. 33:35-40.
29. Murray, H. W., and R. F. Teitelbaum. 1992. L-Arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J. Infect. Dis. 165:513-517.
30. National Institute of Allergy and Infectious Diseases. 1996. Council News 5:1-16.
31. Neote, K., D. DiGregorio, J. Y. Mak, R. Horuk, and T. J. Schall. 1993. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 72:415-425.
32. Noisin, E. L., and F. Villalta. 1989. Fibronectin increases Trypanosoma cruzi amastigote binding and uptake by murine and human macrophages. Infect. Immun. 57:1030-1034.
33. Olivares-Fontt, E., and B. Vray. 1995. Relationship between granulocyte macrophage-colony stimulating factor, tumor necrosis factor-alpha and Trypanosoma cruzi infection of murine macrophages. Parasite Immunol. 17:135-141.
34. Petray, P., M. Castanos-Velez, S. Grinstein, A. Orn, and M. E. Rottenberg. 1995. Role of nitric oxide in resistance and histopathology during experimental infection with Trypanosoma cruzi. Immunol. Lett. 47:121-126.
35. Pietraforte, D., C. Mallozzi, G. Scorza, and M. Minetti. 1995. Role of thiols in the targeting of s-nitroso thiols to red blood cells. Biochemistry 34:7177-7185.
36. Praia, F., J. Wietzerbin, F. G. Pons, E. Falcoff, and H. Eisen. 1984. Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro. Eur. J. Immunol. 14:930-933.
37. Reed, S. G., C. F. Nathan, D. L. Phil, P. Rodricks, K. Shanebeck, P. J. Conlon, and K. H. Grabstein. 1987. Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide: comparison with interferon gamma. J. Exp. Med. 166:1734-1746.
38. Ritter, U., H. Moll, T. Laskay, E. Brocker, O. Velasco, I. Becker, and R. Gillitzer. 1996. Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J. Infect. Dis. 173:699-709.
39. Rosemberg, S., C. J. Chaves, M. L. Higuchi, M. B. Lopes, L. H. Castro, and L. R. Machado. 1992. Fatal meningoencephalitis caused by reactivation of Trypanosoma cruzi infection in a patient with AIDS. Neurology 42:640-642.
40. Schall, T. J. 1991. Biology of the RANTES/sis cytokine family. Cytokine 3:165-183.
41. Schall, T. J., K. Bacon, R. D. D. Camp, J. W. Kaspari, and D. V. Goeddel. 1993. Human macrophage inflammatory protein α (MIP-la) and MIP-1β chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177:821-826.
42. Schall, T. J., and K. B. Bacon. 1994. Chemokines, leukocyte trafficking and inflammation. Curr. Opin. Immunol. 6:865-873.
43. Schneemann, M., G. Schoedom, S. Hofer, N. Blau, L. Guerrero, and A. Schaffner. 1993. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167:1358-1363.
44. Suva, J. S., G. N. Vespa, M. A. Cardoso, J. C. Aliberti, and I. Q. Cunha. 1995. Tumor necrosis factor alpha mediated resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in interferon-activated macrophages. Infect. Immun. 63:4862-4867.
45. Taub, D. D., T. J. Sayers, C. R. Carter, and J. R. Ortaldo. 1995. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155:3877-3888.
46. Vaddi, K., M. Keller, and R. C. Newton. 1997. The chemokine facts book, p. 21-141. Academic Press, Inc., San Diego. Calif.
47. Vespa, G. N. R., F. Q. Cunha, and J. S. Silva. 1994. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect. Immun. 62:5177-5182.
48. Villalta, F., and F. Kierszenbaum. 1983. Role of polymorphonuclear cells in Chagas' disease. I. Uptake and mechanisms of destruction of intracellular (amastigote) forms of Trypanosoma cruzi by human neutrophils. J. Immunol. 131:1504-1510.
49. Villalta, F., and F. Kierszenbaum. 1984. Role of inflammatory cells in Chagas' disease. I. Uptake and mechanisms of destruction of intracellular (amastigote) forms of Trypanosoma cruzi by human eosinophils. J. Immunol. 132:2053-2058.
50. Villalta, F., and F. Kierszenbaum. 1984. Role of inflammatory cells in Chagas' disease. II. Interactions of mouse macrophages and human monocytes with intracellular forms of Trypanosoma cruzi: uptake and mechanisms of destruction. J. Immunol. 133:3338-3343.
51. Villalta, F., and F. Kierszenbaum. 1986. Effects of human colony-stimulating factor on the uptake and destruction of a pathogenic parasite (Trypanosoma cruzi) by human neutrophils. J. Immunol. 135:1703-1707.
52. Villalta, F., M. F. Lima, S. H. Howard, L. Zhou, and A. Ruiz-Ruano. 1992. Purification of a Trypanosoma cruzi trypomastigote 60-kilodalton surface glycoprotein that primes and activates murine lymphocytes. Infect. Immun. 60:3025-3032.
53. Villalta, F., A. Ruiz-Ruano, A. A. Valentine, and M. F. Lima. 1993. Purification of a 74 kDa surface glycoprotein from heart myoblasu that inhibits binding and entry of Trypanosoma cruzi into heart cells. Mol. Biochem. Parasitol. 61:217-230.
54. Villalta, F., Y. Zhang, F. M. Hatcher, E. Motley, and M. F. Lima. Unpublished data.